James Matthew Peyton, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intubation, Intratracheal | 20 | 2023 | 1331 | 2.860 |
Why?
|
Laryngoscopy | 12 | 2023 | 707 | 2.740 |
Why?
|
Laryngoscopes | 6 | 2023 | 146 | 2.550 |
Why?
|
Airway Management | 13 | 2023 | 312 | 2.210 |
Why?
|
Anesthesiology | 8 | 2023 | 1121 | 1.410 |
Why?
|
Anesthesia | 6 | 2021 | 1591 | 1.130 |
Why?
|
Ventilation | 1 | 2022 | 128 | 0.750 |
Why?
|
Respiratory System | 3 | 2022 | 562 | 0.730 |
Why?
|
Anesthetics, Local | 2 | 2023 | 997 | 0.560 |
Why?
|
Auscultation | 1 | 2016 | 38 | 0.530 |
Why?
|
Respiration | 2 | 2023 | 1656 | 0.530 |
Why?
|
Stethoscopes | 1 | 2016 | 30 | 0.510 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 748 | 0.460 |
Why?
|
Education, Medical, Continuing | 1 | 2019 | 825 | 0.460 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2630 | 0.430 |
Why?
|
Laryngeal Masks | 3 | 2023 | 102 | 0.420 |
Why?
|
Video Recording | 4 | 2022 | 965 | 0.410 |
Why?
|
Child | 23 | 2024 | 80134 | 0.350 |
Why?
|
Registries | 4 | 2023 | 8236 | 0.310 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1780 | 0.300 |
Why?
|
Anesthesia, Local | 2 | 2023 | 277 | 0.290 |
Why?
|
Propofol | 2 | 2024 | 602 | 0.280 |
Why?
|
Pandemics | 4 | 2021 | 8663 | 0.250 |
Why?
|
Masks | 2 | 2023 | 208 | 0.210 |
Why?
|
Pediatrics | 4 | 2021 | 3589 | 0.200 |
Why?
|
Bronchoscopy | 3 | 2023 | 909 | 0.180 |
Why?
|
Anesthesia, General | 3 | 2023 | 1174 | 0.180 |
Why?
|
Lidocaine | 1 | 2023 | 538 | 0.180 |
Why?
|
Humans | 35 | 2024 | 761098 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.160 |
Why?
|
Ventilators, Mechanical | 1 | 2020 | 288 | 0.150 |
Why?
|
Emergencies | 1 | 2024 | 1217 | 0.140 |
Why?
|
Equipment Design | 3 | 2020 | 3509 | 0.140 |
Why?
|
Vocal Cord Paralysis | 1 | 2020 | 272 | 0.140 |
Why?
|
Infection Control | 2 | 2021 | 983 | 0.140 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2023 | 1017 | 0.130 |
Why?
|
Videotape Recording | 1 | 2017 | 336 | 0.130 |
Why?
|
Fiber Optic Technology | 1 | 2017 | 290 | 0.130 |
Why?
|
Saxitoxin | 1 | 2015 | 65 | 0.130 |
Why?
|
Hypnotics and Sedatives | 2 | 2021 | 1178 | 0.120 |
Why?
|
Consensus | 2 | 2021 | 3133 | 0.120 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4673 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2021 | 993 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3094 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1661 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3216 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 411 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 792 | 0.100 |
Why?
|
Infant | 10 | 2023 | 36164 | 0.100 |
Why?
|
Trachea | 1 | 2016 | 1090 | 0.080 |
Why?
|
Oxygen | 1 | 2021 | 4226 | 0.080 |
Why?
|
Aerosols | 2 | 2021 | 635 | 0.080 |
Why?
|
Child, Preschool | 5 | 2021 | 42217 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9979 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2022 | 10213 | 0.060 |
Why?
|
Infant, Newborn | 5 | 2023 | 26187 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2023 | 80673 | 0.060 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26068 | 0.050 |
Why?
|
Anesthetics, Intravenous | 1 | 2024 | 394 | 0.050 |
Why?
|
Critical Care | 2 | 2023 | 2690 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 413 | 0.040 |
Why?
|
Lung Compliance | 1 | 2019 | 200 | 0.040 |
Why?
|
Perioperative Period | 1 | 2020 | 252 | 0.040 |
Why?
|
Neuromuscular Blockade | 1 | 2019 | 147 | 0.040 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 251 | 0.040 |
Why?
|
Australia | 1 | 2020 | 1246 | 0.030 |
Why?
|
Mouth | 1 | 2019 | 381 | 0.030 |
Why?
|
Pharynx | 1 | 2019 | 432 | 0.030 |
Why?
|
Tongue | 1 | 2019 | 403 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1518 | 0.030 |
Why?
|
Male | 8 | 2021 | 360675 | 0.030 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1549 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 106 | 0.030 |
Why?
|
Adult | 4 | 2023 | 221083 | 0.030 |
Why?
|
Skull | 1 | 2019 | 818 | 0.030 |
Why?
|
Esophagus | 1 | 2020 | 1033 | 0.030 |
Why?
|
Larynx | 1 | 2019 | 492 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1436 | 0.030 |
Why?
|
Female | 7 | 2021 | 392458 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1913 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1386 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 21357 | 0.030 |
Why?
|
Adolescent | 4 | 2021 | 88271 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2020 | 1860 | 0.020 |
Why?
|
Infant, Premature | 1 | 2019 | 2106 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3881 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6305 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3548 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10755 | 0.010 |
Why?
|
United States | 2 | 2021 | 72337 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12341 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24013 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 64670 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36418 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74219 | 0.010 |
Why?
|
Young Adult | 1 | 2015 | 59199 | 0.000 |
Why?
|
Middle Aged | 1 | 2021 | 220835 | 0.000 |
Why?
|